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Abstract
Both epigenetic alterations and genetic variations play essential roles in tumorigenesis. The epigenetic modification of DNA
methylation is catalyzed and maintained by the DNA methyltransferases (DNMT3a, DNMT3b and DNMT1). DNA mutations
and DNA methylation profiles of DNMTs themselves and their relationships with chicken neoplastic disease resistance and
susceptibility are not yet defined. In the present study, we analyzed the complexity of the DNA methylation variations and
DNA mutations in the first exon of three DNMTs genes over generations, tissues, and ages among chickens of two highly
inbred White Leghorn lines, Marek’s disease-resistant line 63 and -susceptible line 72, and six recombinant congenic strains
(RCSs). Among them, tissue-specific methylation patterns of DNMT3a were disclosed in spleen, liver, and hypothalamus in
lines 63 and 72. The methylation level of DNMT3b on four CpG sites was not significantly different among four tissues of the
two lines. However, two line-specific DNA transition mutations, CpGRTpG (Chr20:10203733 and 10203778), were
discovered in line 72 compared to the line 63 and RCSs. The methylation contents of DNMT1 in blood cell showed significant
epimutations in the first CpG site among the two inbred lines and the six RCSs (P,0.05). Age-specific methylation of DNMT1
was detected in comparisons between 15 month-old and 2 month-old chickens in both lines except in spleen samples from
line 72. No DNA mutations were discovered on the studied regions of DNMT1 and DNMT3a among the two lines and the six
RCSs. Moreover, we developed a novel method that can effectively test the significance of DNA methylation patterns
consisting of continuous CpG sites. Taken together, these results highlight the potential of epigenetic alterations in DNMT1
and DNMT3a, as well as the DNA mutations in DNMT3b, as epigenetic and genetic factors to neoplastic diseases of chickens.
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Introduction
The relationship between somatic epigenetic variations and
genetic mutations of germlines has been an emerging area in
exploring tumorigenesis [1,2]. Epigenetic and genetic mechanisms
all contribute to the development of cancers [3,4,5,6]. Single
nucleotide polymorphisms (SNPs) are quite common genetic
mutations in general populations, and one third of SNPs in
humans have been associated with increased or decreased risks of
various diseases, including cancers [7,8,9,10,11,12]. In contrast,
epigenetics, first described by Conrad Waddington six decades
ago, is defined as the heritable changes in gene expression that
occur without an alteration in DNA sequence [13]. Aberrant DNA
methylation, one of the epigenetic modifications, is mitotically
heritable. The genomes of cancer cells are often hypomethylated
in repetitive elements and hypermethylated in the promoter and/
or the first exon region of tumor suppressor genes compared to
their normal counter-parts [14,15].
Three mainly active DNA methyltransferase genes, including
1HDNMT1, 2HDNMT3a and 3HDNMT3b, are 4Hinvolved in the
epigenetic control of DNA methylation processes at the cytosine of
CpG dinucleotides [16,17]. DNMT1 is the most abundant DNA
methyltransferase in mammalian cells, and is considered to be the
key maintenance methyltransferase in mammals [18,19,20].
5HDNMT3a and 6HDNMT3b function as de novo methyltransfer-
ases and together are responsible for methylation pattern
acquisition during gametogenesis, embryogenesis, and somatic
tissue development as well as maintaining the silence of
transposable elements and enhancing the stability of genome
[21,22,23,24]. The DNA methyltransferases are not limited to
catalyzing DNA methylation, but also involved in the regulation of
gene expression. For example, DNMT3l, the regulator of DNMT3a
and DNMT3b, was identified to have lost DNA methylation level
in cervival cancer patients [25]; DNA mutations in DNMT3b are
of importance in cancer progression [26,27] and ICF syndrome
(immunodeficiency, centromere instability and facial anomalies,
an autosomal recessive disease) in humans [28]. However, the
epigenetic DNA methylation alterations and DNA mutations of
DNMTs themselves and their association with the resistance or
susceptibility of neoplastic disease are still poorly understood.
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2672Neoplastic diseases, defined as any malignant growth or tumor
resulting from abnormal or uncontrolled cell division, are serious
problems in animal and human health [29,30]. The tumors may
spread to other parts of the body through the lymphatic system or
the blood stream. Being a neoplastic disease, Marek’s disease (MD)
is not only a natural model for lymphomas overexpressing
Hodgkin’s disease, but a serious concern to the poultry industry
as a cause of economical losses due to the cost of routine
vaccination against MD [31,32,33,34]. In order to explore the
epigenetic and genetic background and develop better strategies in
preventing the outbreak of neoplastic diseases in chickens, we
initiated explorations to determine if the DNA methylation status
and the single nucleotide polymorphisms (SNPs) of chicken DNA
methyltransferase genes are related to susceptibility or resistance of
neoplastic diseases. We tested this hypothesis in two unique
chicken inbred lines (63 and 72) through pyrosequencing,
sequencing, and quantitative RT-PCR analyses. The highly
inbred line 63, developed and maintained at the 8HAvian Disease
and Oncology Laboratory (ADOL), is highly resistant to Marek’s
disease (MD) tumors induced by the MD virus (MDV), whereas
the highly inbred line 72 is highly susceptible to MD tumors [35].
Moreover, based on the two inbred lines, 19 recombinant
congenic strains (RCS) have been developed. These are the only
RCSs in livestock species. This unique chicken model system
provides a way to elucidate epigenetic and genetic mechanisms
that may influence the susceptibility or resistance to neoplastic
diseases [30,36].
To examine the hypothesis, we first investigated tissue and age
specific methylation profiles in the first exons of DNMT1,
DNMT3a, and DNMT3b among chickens from the MD-resistant
line 63, MD-susceptible line 72, and six RCSs by pyrosequencing
technology. Pyrosequencing is a quantitative technique used to
detect changes in DNA methylation patterns. This technique is
advantageous for analyzing and quantifying the degree of
methylation of multiple continuous CpG sites in one reaction
[37]. Subsequently, DNA mutations were detected by PCR
sequencing. Next, we examined the mRNA expression levels of
the genes using quantitative RT-PCR. Finally, we explored a new
statistical method to classify and test the methylation patterns. The
relationship of epigenetic variations and genetic mutations of the
DNMT genes between the two inbred lines was discussed. Our
results suggested that the aberrant methylation profiles of DNMT1
and DNMT3a as well as CpG to TpG transitions in DNMT3b are
complex epigenetic and genetic factors that may be involved with
neoplastic disease susceptibility or resistance in chickens.
Results
The sketch of DNA methylation analysis of DNMTs in the
inbred lines and RCSs of chickens
Previous studies have documented the distinct features of the
chicken inbred lines 63 and 72 on neoplastic disease resistance or
susceptibility as well as the genetic backgrounds of recombinant
congenic strains (RCSs) [29,36,38,39,40]. Figure 1A shows that
RCSs were intentionally established by crossing Marek’s disease-
resistant line 63 and -susceptible line 72. The F1 was then
consecutively backcrossed to the background line 63 twice. A series
of 19 RCSs were established by sib-mating of the second backcross
Figure 1. Schematic structure of developing the recombinant congenic strains (RCSs) and quantifying DNA methylation levels of
DNMT3b and DNMT3a genes. A. The strategies to develop the 19 RCSs from the background line 63 and donor line 72; B. Upper panel, methylation
analysis region on the first exon of DNMT3b. Position of transcription start site (black arrow), translation start code (ATG) and exons (open boxes)
based on NCBI database (ID NM_001024828). Green box shows the position of the analyzed 6 CpG sites. Lower panel, DNA methylation pyrograms of
six CpG sites in the first exon of DNMT3b in line 63 and line 72 using Pyro Q-CpG system. Grey areas indicate the CpG sites that were analyzed. The
yellow regions indicate internal control regions for automatic assessment of bisulfite conversion (unmethylated C should be fully converted to T).
Blue arrows and pink arrows show the methylation contents in CpG sites 1 and 5 in line 63 and line 72, respectively. C. Upper panel, methylation
analysis region of 8 CpG sites on the first exon of DNMT3a (NCBI ID: 10HNM_001024832). Lower panel, DNA methylation pyrograms of 8 CpG sites in
the first exon of DNMT3b in spleen, liver and hypothalamus. The percentages in each CpG site is the methylation percentage of
mC/(
mC+C) on this
site.
mC: methylated cytosine, C: unmethylated cytosine.
doi:10.1371/journal.pone.0002672.g001
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87.5% background line 63 genome and 12.5% donor line 72
genome. The RCSs and their parental lines are a valuable
resource for genetic and epigenetic analysis of neoplastic disease
resistance and susceptibility.
In this study, we firstly sought to explore the epigenetic
variations of DNA methylation for the three DNA methyltrans-
ferase genes (DNMT3a, DNMT3b and DNMT1) among the two
parental lines and six RCSs through pyrosequencing technology.
We designed PCR primers and sequencing primers for methyl-
ation assays on the first exon of each DNMT gene as shown in
Table 1 and Figure 1B and 1C. Pyrosequencing methylation
analysis is based on using bisulfite converted DNA and PCR to
quantitatively evaluate the methylated cytosine (
mC) from
unmethylated cytosine (C), and to quantify the methylation ratio
by
mC/(
mC+C) at each CpG site. Pyrograms via pyrosequencing
technology exhibit quantitative methylation level in each CpG site.
As illustrated in Figure 1B, DNMT3b has different methylation
profiles on the first exon in two highly inbred lines in blood cell.
The methylation contents of DNMT3b at CpG sites 1 and 5 is seen
to be much higher in line 63 (76% and 73%, respectively) than in
line 72 (5% and 3%) in blood cell, whereas other 4 CpG sites show
no obvious differences between the two lines. From Figure 1C, it is
clear that DNMT3a shows different methylation profiles in spleen,
liver, and hypothalamus, i.e., the average methylation contents of
DNMT3a at 8 CpG sites were much higher in spleen
(76.4%614.6%) compared to that in liver (57.6%620.1%) and
in hypothalamus (44.75%618.9%).
DNA methylation profiles of DNMT3b in different lines,
tissues and ages
To further check the variations of DNA methylation patterns of
the three chicken DNMTs, we examined DNA methylation levels
of DNMT3b in four tissues at two ages of the two lines. Figure 2A,
2B, and 2C exhibited the methylation profiles of the DNMT3b in
the spleen, liver and hypothalamus between lines 63 and 72 at 15
months of age. We found that the methylation levels of DNMT3b
at CpG sites 1 and 5 were significantly higher in line 63 than in line
72 (P,0.01). We thereafter examined the methylation status of
DNMT3b in spleen and liver in line 63 chickens of 2 months of age.
As shown in Figure 3A and 3B, the methylation level of DNMT3b
gene in spleen and liver shows a similar pattern in line 63 chickens
of 2 and 15 months of ages (P.0.05). The results implied that
the DNA methylation of DNMT3b does not have age specificity in
line 63.
Having observed distinct methylation patterns of DNMT3b in the
parental lines 63 and 72, to check the epigenetic inheritance or
epimutations of DNA methylation of the gene, we measured
the methylation status of the DMNT3b gene in blood cell from
thetwoparentallinesandsixRCSs,C,F,J,L,MandT.Asshownin
Figure 2D, we found that, in the eight chicken strains, the
methylation patterns can easily be categorized into two groups, one
of which is extremely similar to each other among 6 RCSs, which
alsocloselyresemblesthe background line 63 incontrasttothedonor
line 72. The results imply that the DNMT3b shows transgenerational
epigenetic inheritance from background line 63 to six RCSs through
meiosis for more than thirteen generations.
Table 1. PCR and pyrosequencing primers and assays for DNMT genes.
Gene
A Assay CpG sites
B Primers Sequence
C
DNMT3b 6: 10203733 Forward 59-GAGGGTTTTTTGGTTGGTTAAGT-39
10203737 Reverse 59-GGGACACCGCTGATCGTTTA CCTCCAACAACAAAACAACAATAT-39
10203747 Sequencing 59-GTTATGAAAAAGGAGAAGAG-39
10203775 Assay sequence 59-TTAYGGTYGG GATGAGGYGG ATTGTAGGGT AGAGTTGATTTTTTT YGAYG
10203778 GGGATTGTAT YGATTTTATT-39
10203790
DNMT3a 8: 107432308 Forward 59-GGTTYGTCGTYGGTTGATTTG-39
107432311 Reverse 59-GGGACACCGCTGATCGTTTAAACCCCCCTACCTCACAACAAC-39
107432314 Sequencing 59-TTGATTTGGATGTGTTTT-39
107432317 Assay sequence 59-GTYGAYGGYGTYGGTTATTATAGGTTTAGGYGTGGTGGTTAYGTTGGGYGA
107432336 GGTAGGGT YGGTGGGTTG -39
107432347
107432354
107432365
DNMT1 4: 49757939 Forward 59-TGGGAAGAGGAAGGGGATAT-39
49757957 Reverse 59-GGGACACCGCTGATCGTTTA TCCCCAATAAAATCTCCTACCA-39
49757946 Sequencing 59-GGAAGAGGAAGGGGATA-39
49757980 Assay sequence 59-TYGATTTTTTGGAAAATAYGTTTAGGATGGTGGGTTGTYGG T YGGAGTTG-39
Universal 59-/Biotin labeled/GGGACACCGCTGATCGTTTA-39
1A: Gene name.
B: DNMT3b, based on the UCSC DNA sequence (May 2006, Chr20) that BLAT from DNMT3b cDNA sequence (NCBI: NM_001024828), it is in the exon1
region of DNMT3b. DNMT3a, based on the UCSC DNA sequence (May 2006, Chr3) that BLAT from DNMT3a cDNA sequence (NCBI: NM_001024832), it is in the exon1
region of DNMT3a. DNMT1, based on the UCSC DNA sequence (May 2006, Chr-Un-random) that BLAT from predicted DNMT1 DNA sequence (NCBI: NM_001475597).
C:
Y and R stand for C/T and G/A, respectively. Bold Y is the CpG sites assayed in each gene.
doi:10.1371/journal.pone.0002672.t001
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DNMT3b
The extremely low methylation levels in the CpG sites 1 and 5
of DNMT3b, compared to other 4 CpG sites, suggested that this
difference could be attributed to single nucleotide polymorphisms
(SNPs) between the two inbred lines. Using DNA sequencing
thereafter, two CpG to TpG transitions located in the same CpG
sites 1 and 5 for DNA methylation analysis, were found in line 72
(Figure 4B) but not in line 63, the RCSs, or a wild-type chicken, a
red jungle fowl (Figure 4A). Taking all this into consideration, the
two line-specific SNPs of DNMT3b appear to be possible genetic
factors that are involved in MD tumor susceptibility in the line 72.
Figure 2. DNA methylation variations of DNMT3b in spleen (A), liver (B) and hypothalamus (C) in line 63 and 72, and in blood cell (D)
in the two parental lines and the six recombinant congenic lines. L63: lines 63;L 7 2: lines 72. C, F, J, L, M and T: six recombinant congenic
strains. n=5 for each line and RCS.
doi:10.1371/journal.pone.0002672.g002
Figure 3. DNA methylation profiles of DNMT3b in spleen (A) and liver (B) at 15 months and 8 weeks old in the line 63. n=5 for each
line.
doi:10.1371/journal.pone.0002672.g003
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negatively or positively regulate the expression level of the gene.
To ascertain the relationships, we then measured the level of
DNMT3b mRNA in spleen, liver, and hypothalamus of 15 month-
old chickens from the two parental lines via real-time quantitative
RT-PCR. Unexpectedly, as shown in Figure 5, the mRNA level of
DNMT3b in spleen was found to be significantly higher in line 63
than in line 72 (P,0.05), whereas it was significantly lower in liver
and hypothalamus of line 63 than line 72 (P,0.01). The results
suggested that DNMT3b may be involved in complicated
regulation and/or expression mechanisms.
Tissue-specific methylation variations of DNMT3a in the
line 72 and line 63
DNMT3a is another de novo DNA methyltransferase like
DNMT3b. To examine the methylation profiles of DNMT3a,w e
conducted DNA methylation analysis of DNMT3a in tissues of
chickens from the two age groups of the lines. As shown in
Figures 6A, we found that the eight continuous CpG sites of
DNMT3a displayed tissue-specific methylation patterns in both
lines at 15 months of age, meaning that the highest level of DNA
methylation was found in spleen (75.2%62.5% in line 63 and
76.6%62.5% in line 72) among the three tissues, followed by liver
(line 63=60.1%64.0%, line 72=61.8%63.4%), and the lowest
level was found in the hypothalamus (44.9%61.7% in line 63,
40.8%63.2% in line 72). Quantitative RT-PCR demonstrated
that the mRNA expression of DNMT3a was significantly higher in
spleen than in liver in the line 63 (n=5, Figure S1A).
Interestingly, we noticed that the methylation levels of DNMT3a
were very similar to each other in the two lines, but only one tissue,
the hypothalamus, among three tissues, showed significantly
higher methylation level in line 63 than in line 72 (P,0.01) at
the first four CpG sites (Figure 6A). Like DNMT3b, the
methylation level of DNMT3a gene also showed a similar pattern
across the two ages (P.0.05), 2 month and 15 month old chickens
, in spleen (Figure 7A and 7B) and liver (Figure 7C and 7D) of both
lines. In addition, as shown in Figure 6B, DNA methylation
patterns of DNMT3a in the two parental lines and six RCSs are
almost the same as that in the blood cell at 12 months of age.
These results indicate that, compared to DNMT3b, DNMT3a is a
tissue-specific de novo DNA methyltransferase, and its methylation
patterns and expression levels varied among the tissues.
Figure 4. Two CpG to TpG transitions in the first exon of DNMT3b by DNA sequencing. A. Blue arrows show the cytosines in CpG sites 1
(Chr20: 10203733) and 5 (Chr20: 10203778) of DNMT3b in the line 63, RCSs (n=3 for each strain) and red jungle fowl (n=1). B. Pink arrows show the
two CpG to TpG transitions in the line 72. n=3.
doi:10.1371/journal.pone.0002672.g004
Figure 5. mRNA expression differences of DNMT3b in spleen, liver and hypothalamus between line 63 and line 72 at 15 months-old
with quantitative RT-PCR. Two replicates for each reaction. n=5 for each line.
doi:10.1371/journal.pone.0002672.g005
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To maintain methylation patterns in daughter cells during DNA
replication, the unmethylated daughter CpG site opposite to a
methylated parental CpG site must be methylated by the
maintenance methyltransferase, DNMT1. It is important, there-
fore, to investigate the methylation status of DNMT1 and compare
it with the de novo methyltransferases in the unique chicken
population. We quantitatively measured DNA methylation levels
of four CpG sites in the exon1 region of DNMT1 in four tissues at
three age stages. Our results indicated that DNMT1 had a similar
methylation pattern in the spleen, liver, and hypothalamus
(Figure 8A, 8B and 8C) between the two inbred lines at 15
months of age, whereas the CpG site 1 in blood cell showed a
significant epimutation among the two parental lines and the six
RCSs (P,0.05) (Figure 8D) at 12 months of age. Interestingly,
comparing the methylation levels of DNMT1 between the two
ages, we found that the methylation level of the CpG site 1 at two
months of age was lower than that at 15 months of age in spleen
(P,0.05) (Figure 9A) and liver (Figure 9C and 9D) for both the
parental lines except in spleen of the line 72 (Figure 9B). The
results indicated that DNMT1 is an epimutation gene with age-
specific methylation patterns in the chickens.
DNA methylation patterns analysis of DNMTs via principal
component test
DNA methylation level is frequently aberrant on different CpG
sites within one CpG island. Thus, analyzing only the average of
methylation levels in continuous CpG sites may blur the major
effect of the single CpG site. On the other hand, point-wise
comparison can only be used to analyze the methylation difference
of the same CpG site between different samples. To explore which
CpG site in a continuous CpG sites region (CpG islands) is mainly
responsible for the fluctuation of the methylation level and
classification of methylation patterns, we developed a new method
to quantitatively evaluate the methylation patterns of DNMTs via a
nonparametric analysis method that transforms principle compo-
nent analysis (PCA) as an exact F test.
Through the exact F test,wecan get theprobabilitylevelofprofile
dissimilarity between any two groups. The P value matrix
constructed from multiple profile comparison is plotted in
Figure 6C. Pink between the groups means no significant differences
(P.0.05), while the color gradient from pink to blue indicates the
extent of significant differences (P,0.05). Consequently, it is easy to
identify the significant tissue-specific differences of methylation
patterns of DNMT3a among the spleen, liver, hypothalamus, and
Figure 6. Tissue-specific DNA methylation variations and patterns analysis of DNMT3a in spleen, liver and hypothalamus (A) in line
63 and line 72, and in blood cell (B) in two lines and six RCSs, C, F, J, L, M and T. L63: line 63;L 7 2: line 72. S, spleen; Li: liver; Hy: hypothalamus.
n=5 for each line and RCS. C. P values matrix among lines and tissues using exact F test for DNA methylation patterns of DNMT3a. 63: line 63; 72: line
72. n=5 for each. D. P values matrix for DNA methylation patterns of DNMT3a among two parental lines 63 and 72, as well as six RCSs. n=5 for each.
Color bar shows the extent of significance level (P values with 2log10(P). e.g., 2log10(0.05)=1.3; 2log10(0.01)=2). Black arrows show P=0.05.
doi:10.1371/journal.pone.0002672.g006
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methylation patterns in hypothalamus between the line 63 and line
72 (P,0.001), while no major differences in spleen, liver, or blood
cell between the two lines were detected (P.0.05). From Figure 6D,
the methylation patterns of DNMT3a among the two parental lines
and six RCSswerenot significantlydifferent inblood cell(Figure 6B,
P.0.05). Similarly for DNMT1, the differences of methylation
patternsamongtheparentallinesandRCSsinbloodcellaswellasin
spleen and liver at two age stages were also analyzed as shown in
Figure 10. From the Figure 10A, we found that RCS C and F in
blood cell showed considerable discrepancy with the two parental
lines in DNMT1 methylation patterns (P,0.05), whereas the other
four RCSs showed no difference from either of the parental lines
(P.0.05). Age-specific methylation pattern differences of DNMT1 at
15 months and two months of age was clearly shown in Figure 10B
(P,0.05). Based on these results, we conclude that the description of
differences and analysis of DNA methylation patterns including
continuous CpG sites can be identified by this newly developed
method.
Discussion
To date, the accumulating evidence of human cancers have been
shown that the increased cytosine methylation levels at CpG
dinucleotides of cancer suppressor genes on promoter regions and/
or exon 1 or decreased methylation levels of repeat elements
throughout the whole genome are highly associated with tumori-
genesis [41]. In our previous report, we found the hypermethylation
pattern of endogenous virus that may be relevant for resistance
against tumors in chickens [31], which encouraged us to trace and
analyzetheepigeneticstatusandgeneticvariationsofthegenefamily
controlling DNA methylation in the unique tumor-resistant or -
susceptible chicken populations. In this study, we underlined the
complexity of epigenetic variations of DNA methylation and genetic
mutations for three DNA methyltransferase genes (DNMTs)i nt w o
highly inbred chicken lines (63 and 72) and six recombinant congenic
strains (RCSs) derived from the two inbred lines. To our knowledge,
this study is the first to explore the DNA methylation variation
profiles of DNMTs in tumor resistant or susceptible chickens. Due to
lack of knowledge about the promoter locations of these genes in
animals, the pilot assessment of DNA methylation was done on the
first exon of these genes. Some of these variations may help us
uncover the trigger of the susceptibility or resistance to neoplastic
disease in chickens.
We found that the three DNMTs have unique epigenetic and
genetic patterns in the chicken population. Among them, DNMT1
and DNMT3a showed epimutations of DNA methylation on the
first exon, i.e., tissue-specific methylation of DNMT3a and age-
specific methylation of DNMT1. Interestingly, the age-specific style
shown by DNA methylation of DNMT1 may contribute to some
forms of amyloidosis that develops with aging [42]. No DNA
mutations of these two genes indicated that the regulation of
related gene expression should be manipulated by epimutations of
these genes. In addition, the mRNA expression data in the spleen
and liver showed that high CpG methylation levels in the first exon
of DNMT3a coincided with high transcription levels in spleen, and
Figure 7. DNA methylation profiles of DNMT3a in spleen (A, B) and liver (C, D) at 15 months and 8 weeks old in line 63 and line 72.
n=5 for each line.
doi:10.1371/journal.pone.0002672.g007
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in line 63 birds (Figure S1A). Moreover, the similar CpG
methylation patterns of DNMT1 in liver were also consistent with
similar transcription levels (Figure S1B) in both lines 63 and line
72. The results were in good agreement with reported methylation
studies, that is, the methylation level on the exons of MHC (Major
Histocompatibility Complex) genes were positively related to the
expression levels [43,44]. Our unpublished data indicated that the
tumor numbers induced by MDV are different among tissues in
line 63 and line 72. Thus it is possible that the tissue-specific
epimutations of DNMT3a is associated with the tumor number
variations in different tissues.
On the contrary, CpG sites 2, 3, 4 and 6 in the first exon of
DNMT3b (Fgiure 1) did not show statistical difference among the
lines in tissues of varied age groups (Figure 2 and 3). Compared to
resistant line 63, the six RCSs and a wild type chicken (red jungle
fowl) (Figure 5A), the ‘‘methylation differences’’ at CpG sites 1 and
5 (Figure 2) of DNMT3b, hypermethylation in line 63 and
unmethylation in line 72, are actually due to the CpG to TpG
transitions in MD-susceptible line 72 (Figure 5B). A further analysis
disclosed that the two transitions are synonymous mutations, but
the two translation start codes (ATG) were created through the
two mutations (Figure S2B). Because of the mutations, a new
transcriptional binding site, PAX5 (B-cell specific activator
protein), is discovered at the second mutation region in line 72,
which replaced the original binding site, NUDR (Nuclear DEAF-
1-related protein), on the same site in line 63 (Figure S2A and
S2B). Therefore, we postulate that this crucial replacement might
be related to susceptibility of neoplastic disease. It is reported that
DNMT3b is an alternative splicing gene in mammals [45,46].
Further investigations are needed to confirm whether or not there
are harmonious combinations between the splicing structures,
methylation status, and the two SNPs in chickens, as well as the
genetic effect on chicken MD susceptibility or resistance. For the
discrepant mRNA expression levels of DNMT3b among different
tissues, that is, higher expression in line 63 than in line 72 in spleen,
but lower expression in line 63 than line 72 in liver and
hypothalamus, further investigations will follow to determine the
effects of the DNA methylation variation on the promoter region
of DNMT3b among different tissues and to explore any network
mechanisms that may be involved.
Most importantly, the methylation patterns of the genes clearly
exhibited an epigenetic inheritance of interest. To date, only a few
genes have been shown to display epigenetic inheritance in
mammals, such as axin-fused (Axin
Fu) [47] and yellow agouti (A
vy)
[48]. This observation supports that methylation patterns could be
viewed as epigenotypes referring to mitotically heritable patterns
of DNA methylation at CpG sites [49,50]. The two highly inbred
parental lines, 63 and 72, and the RCSs constitute unique
resources for exploration of the nature of DNMT1, DNMT3a,
and DNMT3b, which allow us to quantitatively measure
methylation alterations of the three DNMTs in order to monitor
whether epigenetic inheritance or epimutations of parental
methylation patterns are passed on to subsequent generations.
From the detailed methylation patterns of the parental lines and
the RCSs plotted in Figures 2D (DNMT3b), 6B (DNMT3a), and 8B
(DNMT1) we recognized that the methylation pattern of DNMT3a
and DNMT3b in blood cell were inherited from the background
Figure 8. DNA methylation variations of DNMT1 in spleen (A), liver (B) and hypothalamus (C) in the lines 63 and 72, and in blood cell
(D) in the two parental lines and six recombinant congenic lines. L63: lines 63;L 7 2: lines 72. C, F, J, L, M and T: six recombinant congenic
strains. * P,0.05. n=5 for each line and RCS.
doi:10.1371/journal.pone.0002672.g008
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PLoS ONE | www.plosone.org 8 July 2008 | Volume 3 | Issue 7 | e2672Figure 9. DNA methylation variations of DNMT1 in spleen (A, B) and liver (C, D) at 15 months and 8 weeks old in line 63 and line 72.*
P,0.05. n=5 for each line.
doi:10.1371/journal.pone.0002672.g009
Figure 10. Exact F test for DNA methylation patterns of DNMT1. A. P values matrix among the two parental lines 63 and 72, as well as six RCSs,
C, F, J, L, M and T. n=5 for each. B. P values matrix among the lines, tissues on ages. 63: line 63; 72: line 72; S: spleen; Li: liver. 15: 15 months old; 8: 8
weeks old. n=5 for each. Color bar shows the significance level (P values with 2log10(P). e.g., 2log10(0.05)=1.3; log10(0.01)=2). Black arrows show
P=0.05.
doi:10.1371/journal.pone.0002672.g010
Epigenetics of DNMTs Family
PLoS ONE | www.plosone.org 9 July 2008 | Volume 3 | Issue 7 | e2672line 63, whereas the methylation of DNMT1 in blood cell showed
epimutaitons at the first CpG site between the six RCSs and their
two parental lines. The plasticity of methylation patterns in
DNMT1 might have offered reasonable explanation of the
variability of resistance to MD among a series of 19 recombinant
congenic strains (unpublished data). It is worth noting that after 13
generations of sib-mating, DNMT3a and DNMT3b in the RCSs
still kept the methylation pattern of the background line 63, which
resulted from epigenetic transgenerational inheritance. Although
the epigenotype in the epigenome is far less stable than genotype of
the DNA genome, the epigenetic inheritance of DNMT3a and
DNMT3b and epimutations of DNMT1 in blood cell gives us an
important clue on how to combine the epigenetic and genetic
information to prevent neoplastic disease in chickens.
In our quantitative methylation analysis, DNA methylation
patterns are continuous measurements of CpG sites. Traditional
analysis methods based on normal distribution, such as t-test and
ANOVA, are thus not suitable for the data characteristics. For
pattern identification, when considering the most widely used
methods, such as k-means, self-organizing map (SOM) and
hierarchical clustering analysis, it has been argued recently that
distance based methods generate local solutions that are not
necessarily meaningful. Furthermore, identifying a priori the
number of clusters remains, in general, an open problem.
Therefore, determining the right pattern is a critical issue in
epigenomic analysis. However, comparing methylation patterns
between groups will allow us to test the influence of DNA
methylation patterns on MD risk. In this study, we adopted a new
method of analysis, known as principal component test, to classify
DNA methylation patterns and validated it’s feasibility in
computational epigenetics. In principle, the PCA is a multivariate
technique, which examines the relationships among the CpG sites
by producing eigenvalue and principal component scores with
variance, and then summarizes the CpG data in reduced
dimensions. To assess a pattern-wise comparison, an exact F test
was finally carried out to get a P value from the PCA
transformation. This method can effectively classify the DNA
methylation patterns in a continuous CpG sites region as
illustrated in Figures 6, 10, S3, S4 and S5.
In summary, we characterized the unique epigenetic profiles
and DNA mutations of three DNA methytransferase genes in
chickens. Tissue-specific methylation pattern of DNMT3a, age-
specific methylation pattern of DNMT1, and CpG to TpG
transitions in DNMT3b might be associated with susceptibility of
MD, which suggests new possibilities for etiological study, MD
control, and genetic breeding of MD resistant chickens using these
epigenetic and genetic factors.
Materials and Methods
Experimental Animals and Samples
Lines 63 and 72 White Leghorn chickens were initially selected
at the Avian Disease and Oncology Laboratory in 1939 for tumor
resistance or susceptibility induced by Marek’s disease virus
(MDV) and avian leukosis virus. Nineteen recombinant congenic
strains (RCS) were developed using line 63 as the background line
and line 72 as the donor line (Figure 1). Samples were collected
from the two highly inbred chicken lines as well as six RCSs, M, T,
F, J, C and L, which showed higher to lower MD tumor incidence
difference from unvaccinated and vaccinated treatment results
(our unpublished data). The line 63 is resistant to MD whereas the
line 72 is susceptible. Heparinized blood samples were collected
from each of the chickens prior to euthanasia. Five blood samples
were collected from females of each parental line and each RCS at
2, 12 and 15 months of age and stored at 220uC until analyses.
Tissue samples of line 63 and line 72 at 2 and 15 months of age
were obtained from three organs: liver, spleen and hypothalamus.
Tissue samples were frozen in liquid nitrogen immediately at
sampling and stored at 280uC until analyses. All procedures
followed standard animal care and use guidelines.
DNA extraction and bisulfite treatment
DNA was extracted from 20 ml red blood cells or 3 mm
3 tissue
samples using the phenol-chloroform method. DNA was precip-
itated in ethanol, pelleted and redissolved in TE (pH 8.0), and
DNA concentration was measured by a spectrophotometer (Bio-
Rad). Sodium bisulfite conversion of each sample of genomic
DNA (1 mg) was performed using EZ DNA Methylation Golden
Kit as described in the manufacturer’s instructions (ZYMO
Research). Bisulfite converted DNA was eluted in 20 ml elution
buffer (ZYMO Research).
PCR and sequencing primers used in pyrosequencing
assay
PCR assays were designed to amplify multiple CpG dinucleotides
sites in the first exon of DNMT1, DNMT3a and DNMT3b.T h e
principle of primer design is that the primers do not cover any CpG
sites as far as possible. As shown in Table 1, forward and reverse
primers of PCR assays and sequencing primer of pyrosequencing
methylation assays were designed using PSQ Assay Design software
(Biotage, Sweden). Based on the BLAT results from UCSC Genome
Browser and the requirement of pyrosequencing techniques (Pyro-
MarK ID, Biotag, Sweden), one 6-CpG-site region of the DNMT3b
on chicken chromosome 20, 8-CpG-site region of the DNMT3a on
chromosome 3 and 4-CpG-site region of the DNMT1 on one of
microchromosome were analyzed (Table 1, Figure 1, Figure S6A,
S6B and S6C). A biotin labeled universal primer (59-GGGA-
CACCGCTGATCGTTTA-39) was used in the PCR assays [51].
The59endofeachreverseprimerwastailedwiththesequenceasthe
universal primer (Table 1) [51].
Hot start PCR amplification
The hot start PCR was carried out in a 30 ml solution for
DNMTs: 1.5 ml diluted bisulfite treated DNA (1:5 dilution),
16PCR buffer, 0.2 mM dNTPs, 0.5 mM forward primer,
0.05 mM reverse primer with universal tail, 0.45 mM biotin
labeled universal primer, and 0.75 U Qiagen’s Hotstar Taq
DNA polymerase (Qiagen Inc.). PCR cycling conditions were
95uC for 15 min, followed by 50 cycles of 94uC for 30 sec, 60uC
for 45 sec, and 72uC for 45 sec, and a final incubation at 72uC for
10 min. PCR product quality verification was carried out on 1.5%
agarose gels with ethidium bromide.
Pyrosequencing methylation assays
Based on the concentration of the hot start PCR product,
10,25 ml PCR product was used for each pyrosequencing
reaction. Pyrosequencing methylation analysis was carried out
using the Pyro Q-CpG system (PyroMark ID, Biotage, Sweden)
according to manufacture’s protocol. In brief, the biotin labeled
PCR products were bound to Streptavidin coated Sepharose beads
(GE Healthcare Bio-sciences AB, Sweden). The Sepharose beads
containing the immobilized PCR product were purified in 70%
ethanol for 5 sec, denatured in Denature buffer (Biotage) for 5 sec,
and washed with washing buffer (Biotage) for 10 sec using the
Pyrosequencing Vacuum Prep Tool (Biotage). Then, 0.5 mM
sequence primer was annealed to the purified single-stranded PCR
product in annealing buffer (Biotage) and pyrosequencing was
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methylation was expressed for each cytosine locus on CpG sites
as the percentage of
mC/(
mC+C). Non-CpG cytosine residues
were used as internal controls to verify bisulfite conversion.
PCR and DNA sequencing
The methylation assayed region of DNMT3b was amplified by
PCR from the whole genome for each sample. The forward and
reverse PCR primers are 59-GGCAGCCATGAAAAAGGAGA-
39 and 59-GGCAGCAGTGTCCTTAGTGG-39, respectively.
PCR cycling conditions were 95uC for 15 min, followed by 30
cycles of 94uC for 30 sec, 62uC for 45 sec, and 72uC for 20 sec,
and a final incubation at 72uC for 10 min. The amplified region
was purified from 1.5% UltraPura Agarose (Invitrogen, Inc.) gel
through QIAquick Gel Extraction Kit (Qiagen, Inc.), and the
purified fragments were sequenced using ABI 3730.
Real-time quantitative RT-PCR
Total RNA of 5 individuals from line 72 and line 63 was
extracted from spleen, liver and hypothalamus using RNeasy Midi
kit (Qiagen, Inc.). The first strand cDNA was synthesized from
total RNA using SuperScript
TM III Reverse Transcriptase
(Invitrogen). Samples were then analyzed by real time RT-PCR
using an iCycler iQ PCR system (Bio-Rad). The real time RT-
PCR reactions were performed in a final volume of 20 ml with a
QuantiTect SYBR Green PCR Kit (Qiagen) according to the
manufacture’s instructions. Each reaction has two replicates. The
mRNA expression of DNMT3b was normalized against the
housekeeping gene GAPDH (glyceraldehyde 3-phosphate dehy-
drogenase) cDNA in the corresponding samples.
Statistical analysis
In this research, point-wise comparison was carried out to
analyze the difference of DNA methylation levels at each CpG site
between two parental lines and six RCSs. Student’s t test was used
to analyze the difference of RNA expression levels of DNMTs
between two lines.
In addition, we developed a new method called principal
component test to evaluate the significant difference of methyla-
tion patterns consisting of continued CpG sites, which was done
through the transformation of q-fold principle components (PC)
[52]. In brief, the significance test of DNA methylation patterns of
the eight populations (lines, tissues and ages of chickens) is
conducted on the exact F statistic for high-dimension data. The
objective is to assess if the two groups to which the n individuals
belong are statistically distinguishable.
Let n
(1) and n
(2),n
(1)+n
(2)=n, represent the numbers of
individuals in two populations, respectively, to be compared.
Assume each individual has a measure of several continued CpG
sites. Denote X=(x1,x2…xn), a p6n matrix representing meth-
ylation percentages on each CpG site.
Assume xi,N(mi, S), the null hypothesis to be tested is
H0 : m1~m2~   mn ð1Þ
Let us denote   X X~X1n1
0
n
.
n, and let D be a p6q matrix consisting
of the first q (1,q,min(n, p)) eigenvectors of the solution of the
following general eigenvalue problem
X{  X X
  
X{  X X
   0
D~diag X{  X X
  
X{  X X
   0   
DL, ð2Þ
where L is the q6q diagonal matrix of q largest eigenvalues.
If H0 holds, the statistic
F~
n{q{1
q
k
0
Z
0
G
 1Zk, ð3Þ
exactly follows F distribution with q and n-q-1 as the degrees of
freedom, where Z=D9X, G~ZI n{ 1
n1n1
0
n{kk
0   
Z
0
. k is a
vector calculated according to following equation
k~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n 1 ðÞ n 2 ðÞ
n 1 ðÞ zn 2 ðÞ
s
1
n 1 ðÞ1n 1 ðÞ
{ 1
n 2 ðÞ1n 2 ðÞ
 !
: ð4Þ
For a given n and p, the power of this statistic is dependent on
the choice of q, the number of principals to be considered. We
determined this parameter based on a cumulative energy content
(CEC) criterion. That is, the q principals can capture at least 85%
variance in the data.
Supporting Information
Figure S1 mRNA expression levels of DNMT3a and DNMT1
using quantitative RT-PCR. A. The level of DNMT3a in spleen
and liver from line 63 at 15 months-old. B. The level of DNMT1
in liver between line 63 and line 72 at 15 months-old. Two
replicates for each reaction. n=5 for each line and tissue.
Found at: doi:10.1371/journal.pone.0002672.s001 (0.80 MB
DOC)
Figure S2 Predicted transcriptional binding sites at the studied
CpG sites region of DNMT3b in the line 63 (A) and line 72 (B).
Open boxes show the two CpG (A) to TpG (B) transitions.
Underlined sequences are the predicted core regions of transcrip-
tional binding sites using Matinspector software available on
website www.genomatix.de. Transcription factors: DMP1, also
named DMTF1 (Cyclin D binding myb-like transcription factor
1). In vivo, DMP1 is a physiological regulator of the Arf-p53
pathway, an oncogene-suppressor pathway; PLAG1 (Pleomorphic
adenoma gene) encodes a developmentally regulated, SUMOy-
lated and phosphorylated zinc finger transcription factor,
recognizes a specific bipartite DNA consensus sequence regulating
expression of a spectrum of target genes. PLAG1 is defined by
various studies as a tumor-suppressor gene; NUDR, Nuclear
DEAF-1-related protein, is a transcriptional regulatory factor with
sequence similarity to developmental and oncogenic proteins.
NUDR produced a 65–70% repression of the nuclear ribonu-
cleoprotein A2/B1 promoter activity; PAX5, B-cell-specific
activator protein. PAX5 is essential for the transcriptional control
of B cell commitment, development and function as well as in B
cell tumorigenesis.
Found at: doi:10.1371/journal.pone.0002672.s002 (1.19 MB TIF)
Figure S3 Exact F test for DNA methylation patterns of
DNMT3b. A. P values matrix among two parental lines 63 and
72, as well as six RCSs, C, F, J, L, M and T. n=5 for each. B. P
values matrix among lines and tissues. 63: line 63; 72: line 72; S:
spleen; Li: liver. Color bar shows the extent of significance level (P
values with 2log10(P). e.g., 2log10(0.05)=1.3; 2log10(0.01)=2).
Black arrows show P=0.05.
Found at: doi:10.1371/journal.pone.0002672.s003 (1.47 MB TIF)
Figure S4 P values matrix with exact F test for DNA
methylation patterns of DNMT3a among lines, tissues and ages.
63: line 63; 72: line 72; S: spleen; Li: liver; Hy: hypothalamus; B:
blood cell. 15: 15 months old; 8: 8 weeks old. n=5 for each. Color
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PLoS ONE | www.plosone.org 11 July 2008 | Volume 3 | Issue 7 | e2672bar shows the extent of significance level (P values with 2log10(P).
e.g., 2log10(0.05)=1.3; 2log10(0.01)=2). Black arrows show
P=0.05.
Found at: doi:10.1371/journal.pone.0002672.s004 (1.01 MB TIF)
Figure S5 P values matrix with exact F test for DNA methylation
patterns of DNMT1 among lines and tissues. 63: line 63; 72: line 72;
S: spleen; Li: liver; Hy: hypothalamus; B: blood cell. n=5 for each.
Color bar shows the extent of significance level (P values with
2log10(P). e.g., 2log10(0.05)=1.3; 2log10(0.01)=2). Black arrows
show P=0.05.
Found at: doi:10.1371/journal.pone.0002672.s005 (0.95 MB TIF)
Figure S6 BLAT results of chicken DNMT3B (S6A), DNMT3A
(S6B) and DNMT1 (S6C) using UCSC Genome Browser. Brown
boxes show the first exon that including the analyzed CpG sites in
each gene.
Found at: doi:10.1371/journal.pone.0002672.s006 (5.39 MB TIF)
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